| P50 | author | Mercedes Cao | Q88074398 |
| P2093 | author name string | Luis Bolaños | |
| | Francisco Valdés | |
| | Angel Alonso | |
| | Juan Mosquera | |
| | Santiago Rodríguez | |
| | Eduardo Vázquez | |
| | Francisco Pita | |
| | Bruna N Leite | |
| | Tamara Ferreiro | |
| | María Trigás | |
| P2860 | cites work | Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype | Q24613907 |
| | Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome | Q24685473 |
| | Eosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy: Is Simultaneous Systemic Lupus Erythematosus Associated With Clinical Manifestations?: A Case Report and Review of the Literature | Q26777537 |
| | Thrombotic microangiopathy associated with the hypereosinophilic syndrome | Q33365891 |
| | A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders | Q33371578 |
| | Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome | Q33372129 |
| | Complement inhibitor eculizumab in atypical hemolytic uremic syndrome | Q33385154 |
| | Thrombotic microangiopathy and associated renal disorders | Q33402372 |
| | STEC-HUS, atypical HUS and TTP are all diseases of complement activation | Q33403359 |
| | The non-casual relation between eosinophilia and thrombotic microangiopathy | Q33403445 |
| | Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | Q33403607 |
| | Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. | Q33405726 |
| | Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases | Q33406434 |
| | Renal recovery with eculizumab in atypical hemolytic uremic syndrome following prolonged dialysis | Q33406855 |
| | Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome | Q33408211 |
| | How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome | Q33413697 |
| | Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases | Q33414142 |
| | Atypical Hemolytic-Uremic Syndrome: A Clinical Review | Q33414321 |
| | Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab | Q33415314 |
| | Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab | Q33417375 |
| | Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan | Q33424274 |
| | Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy | Q36802256 |
| | Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations | Q37322141 |
| | Inhibiting the C5-C5a receptor axis | Q37872896 |
| | Epidemiology and clinical features of systemic vasculitis | Q38120695 |
| | Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management | Q38164506 |
| | Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri | Q40052746 |
| | Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). | Q41622904 |
| | Hypereosinophilic syndrome developing after prednisolone therapy for autoimmune hemolytic anemia | Q44702369 |
| | Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. | Q51059202 |
| | [Autoimmune hemolytic anemia with eosinophilia in elderly patient] | Q71784919 |
| | Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome | Q84332714 |
| | Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome | Q84893066 |
| P433 | issue | 1 | |
| P921 | main subject | atypical hemolytic uremic syndrome | Q17165460 |
| | granulomatosis with polyangiitis | Q1161568 |
| P304 | page(s) | 91-97 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | CEN case reports | Q27725774 |
| P1476 | title | Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship | |
| P478 | volume | 6 | |